the circumstances under which the research would be terminated. Research 
involving drug therapy may be terminated by your physician should you not 
receive benefit or should life-threatening side effects occur. Should new 
information become available regarding a superior treatment for your type of 
disease, you will be informed and you should discuss further therapy with your 
doctor at that time. 
AIDS Antibody Test 
As part of your participation in this protocol, your blood will be tested for 
antibodies to the human immunodeficiency virus (HIV) , the virus that causes 
AIDS. If you are found to have these antibodies, or if you have been 
diagnosed as having AIDS you should be aware of the following policy: 1) your 
doctor will notify you promptly of the result, 2) your doctor will offer you, 
your spouse, and current and/or ongoing sexual partner (s) whom you identify, 
information on the meaning of the test and how to prevent the spread of this 
infection, 3) because HIV can be transmitted in several ways, it is important 
that you inform these partners that any or all may have been exposed to the 
HIV virus, and encourage them to be tested. If you request, we will assist 
you in notifying your current and/or ongoing partner(s), and arrange 
counseling, 4) in the event that you are unwilling or unable to notify any or 
all of these partners, we are responsible for attempting to assure that they 
have been made aware of their possible exposure to HIV. All reasonable 
attempts will be made to protect your identity. (For example, the partner (s) 
will be notified that they have been exposed to HIV without naming the 
individual who exposed them) . Some of these notification and counseling 
procedures may be carried out through arrangements with, or referral to, local 
public health departments. 
In addition, if you are found to have this antibody in your bloodstream, you 
will not be eligible for entry onto this study. The treatments that are 
administered on this study that you would otherwise enter may alter the immune 
system in such a way that the treatment might worsen the viral infection. 
Recombinant DNA Research, Volume 18 
[745] 
